Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
 BACK TO LIST

Laboratory Report

Patient
Name: Taylor, , Eileen,
DOB: 11-DEC-1951 (Age: 73)
Gender: female
Address:
39 Slater harbors
LE17 Smithtown (United Kingdom)
ID: 6172-576075-7 (ECI)
Report
Date: 28-APR-2025
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Leicester Royal Infirmary
LE2 7 Leicester (United Kingdom)
Specimen
Collected: 28-APR-2025

Chemistry

Test 28-APR-2025 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 214.6 H 130 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 108.3 35 - 175 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 139.6 0 - 190 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 53.4 50 - 100 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows mildly elevated total cholesterol, while LDL, HDL, and triglycerides are within normal limits. Cardiovascular risk should be assessed in the clinical context, but no acute laboratory abnormalities are present. Consider lifestyle modification and monitoring lipid profile as appropriate.